A NEW INFARMADE R&D PROJECT WITHIN THE AREA OF NEUROLOGY RECEIVES A HELP FROM THE CDTI
Seville – 28th June 2019
Last March, the Center for Industrial Technological Development (CDTI) granted INFARMADE a grant for the development of the Project of Research and Development called “DEVELOPMENT OF NEW GENERIC DRUGS FOR THE TREATMENT OF DISEASES IDEOPATHIC PULMONARY”.
The general objective of this project is the development of the first generic pharmaceutical specialties of drugs from the group of immunosuppressants, based on the only principle active ingredient that has demonstrated clinical efficacy for the treatment and improvement of evolution of chronic inflammatory lung diseases.
Likewise, the Resulting medicines will have cheaper prices than those used as a reference, which will allow both reducing costs for public systems health, such as expanding the number of patients who can access new next-generation drugs.
Fondo Europeo de Desarrollo Regional (FDER)
Una manera de hacer Europa